First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Reaches New 1-Year High at $162.54

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)’s stock price hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $162.54 and last traded at $162.54, with a volume of 2706 shares. The stock had previously closed at $159.62.

First Trust NYSE Arca Biotechnology Index Fund Stock Up 0.7 %

The company has a market cap of $1.21 billion, a P/E ratio of 17.20 and a beta of 0.86. The firm has a 50 day moving average of $152.25 and a 200-day moving average of $151.74.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Independence Bank of Kentucky bought a new position in First Trust NYSE Arca Biotechnology Index Fund in the first quarter worth approximately $31,000. Principal Securities Inc. bought a new stake in First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter valued at $32,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 14.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 932 shares of the company’s stock valued at $148,000 after acquiring an additional 118 shares in the last quarter. Main Street Financial Solutions LLC bought a new stake in First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter valued at $201,000. Finally, Jones Financial Companies Lllp bought a new stake in First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter valued at $201,000.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.